hexamethonium has been researched along with Abscess in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Abscess: Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OHYAMA, Y | 1 |
| AOKI, Y | 1 |
| TAMURA, K | 1 |
| KAWABE, A | 1 |
| IMAI, T | 1 |
| KIKUTA, R | 1 |
| EGUCHI, A | 1 |
| MASHIMA, T | 1 |
| OGURO, C | 1 |
1 other study available for hexamethonium and Abscess
| Article | Year |
|---|---|
A CASE OF ACUTE MYOCARDIAL INFARCTION WITH INITIAL ST SEGMENT DEPRESSIN.
Topics: Abscess; Alanine Transaminase; Anal Canal; Arrhythmias, Cardiac; Aspartate Aminotransferases; Blood | 1964 |